{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:58:50Z","timestamp":1790290730819,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009664","name":"Sociedad Espa\u00f1ola de Cardiolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Iron deficiency (ID) is common in patients with heart failure (HF) and is associated with poor outcomes, yet its role in the pathophysiology of HF is not well-defined. We sought to determine the consequences of HF neurohormonal activation in iron homeostasis and mitochondrial function in cardiac cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>HF was induced in C57BL\/6 mice by using isoproterenol osmotic pumps and embryonic rat heart-derived H9c2 cells were subsequently challenged with Angiotensin II and\/or Norepinephrine. The expression of several genes and proteins related to intracellular iron metabolism were assessed by Real time-PCR and immunoblotting, respectively. The intracellular iron levels were also determined. Mitochondrial function was analyzed by studying the mitochondrial membrane potential, the accumulation of radical oxygen species (ROS) and the adenosine triphosphate (ATP) production.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Hearts from isoproterenol-stimulated mice showed a decreased in both mRNA and protein levels of iron regulatory proteins, transferrin receptor 1, ferroportin 1 and hepcidin compared to control mice. Furthermore, mitoferrin 2 and mitochondrial ferritin were also downregulated in the hearts from HF mice. Similar data regarding these key iron regulatory molecules were found in the H9c2 cells challenged with neurohormonal stimuli. Accordingly, a depletion of intracellular iron levels was found in the stimulated cells compared to non-stimulated cells, as well as in the hearts from the isoproterenol-induced HF mice. Finally, neurohormonal activation impaired mitochondrial function as indicated by the accumulation of ROS, the impaired mitochondrial membrane potential and the decrease in the ATP levels in the cardiac cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>HF characteristic neurohormonal activation induced changes in the regulation of key molecules involved in iron homeostasis, reduced intracellular iron levels and impaired mitochondrial function. The current results suggest that iron could be involved in the pathophysiology of HF.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13578-021-00605-5","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T18:02:58Z","timestamp":1621274578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Neurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells"],"prefix":"10.1186","volume":"11","author":[{"given":"M.","family":"Tajes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"D\u00edez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Enjuanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Moliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jim\u00e9nez-Marrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. G.","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Alcoberro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gonz\u00e1lez-Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Garc\u00eda-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ya\u00f1ez-Bisbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-720X","authenticated-orcid":false,"given":"J.","family":"Com\u00edn-Colet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"605_CR1","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/ejhf.549","volume":"18","author":"N Farr\u00e9","year":"2016","unstructured":"Farr\u00e9 N, Vela E, Cl\u00e8ries M, et al. Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients. Eur J Heart Fail. 2016;18:1132\u201340.","journal-title":"Eur J Heart Fail"},{"key":"605_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0735-1097(92)90167-L","volume":"20","author":"M Packer","year":"1992","unstructured":"Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"605_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","volume":"14","author":"J Hartupee","year":"2017","unstructured":"Hartupee J, Mann DL. Neurohormonal activation in heart failure with reduced ejection fraction. Nat Rev Cardiol. 2017;14:30\u20138.","journal-title":"Nat Rev Cardiol"},{"key":"605_CR4","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","volume":"54","author":"F Triposkiadis","year":"2009","unstructured":"Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas F, Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol. 2009;54:1747\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"605_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0002-9149(78)90162-5","volume":"41","author":"JA Thomas","year":"1978","unstructured":"Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 1978;41:233\u201343.","journal-title":"Am J Cardiol"},{"key":"605_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0300-8932(04)77113-4","volume":"57","author":"ME Roig","year":"2004","unstructured":"Roig ME. Clinical use of markers of neurohormonal activation in heart failure. Rev Esp Cardiol. 2004;57:347\u201356.","journal-title":"Rev Esp Cardiol"},{"key":"605_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jacc.2010.05.011","volume":"56","author":"DG Kramer","year":"2010","unstructured":"Kramer DG, Trikalinos TA, Kent DM, Antonopoulos GV, Konstam MA, Udelson JE. Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. J Am Coll Cardiol. 2010;56:392\u2013406.","journal-title":"J Am Coll Cardiol"},{"key":"605_CR8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC [published correction appears in Eur Heart J. 2016 Dec 30]. Eur Heart J. 2016;37:2129\u2013200.","journal-title":"Eur Heart J"},{"key":"605_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","volume":"165","author":"IT Klip","year":"2013","unstructured":"Klip IT, Comin-Colet J, Voors AA, et al. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013;165:575\u201382.","journal-title":"Am Heart J"},{"key":"605_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","volume":"7","author":"S von Haehling","year":"2019","unstructured":"von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker SD. Iron deficiency in heart failure: an overview. JACC Heart Fail. 2019;7:36\u201346.","journal-title":"JACC Heart Fail"},{"key":"605_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12872-018-0942-x","volume":"18","author":"J Gonz\u00e1lez-Costello","year":"2018","unstructured":"Gonz\u00e1lez-Costello J, Com\u00edn-Colet J, Lup\u00f3n J, et al. Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study. BMC Cardiovasc Disord. 2018;18:206.","journal-title":"BMC Cardiovasc Disord"},{"key":"605_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.recesp.2015.08.017","volume":"69","author":"C Enjuanes","year":"2016","unstructured":"Enjuanes C, Bruguera J, Grau M, et al. Iron status in chronic heart failure: impact on symptoms, functional class and submaximal exercise capacity. Rev Esp Cardiol (Engl Ed). 2016;69:247\u201355.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"605_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijcard.2014.03.169","volume":"174","author":"C Enjuanes","year":"2014","unstructured":"Enjuanes C, Klip IT, Bruguera J, et al. Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study. Int J Cardiol. 2014;174:268\u201375.","journal-title":"Int J Cardiol"},{"key":"605_CR14","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436\u201348.","journal-title":"N Engl J Med"},{"key":"605_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/eurheartj\/ehr504","volume":"34","author":"J Comin-Colet","year":"2013","unstructured":"Comin-Colet J, Lainscak M, Dickstein K, et al. The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. Eur Heart J. 2013;34:30\u20138.","journal-title":"Eur Heart J"},{"key":"605_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ejhf.823","volume":"20","author":"SD Anker","year":"2018","unstructured":"Anker SD, Kirwan BA, van Veldhuisen DJ, et al. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. Eur J Heart Fail. 2018;20:125\u201333.","journal-title":"Eur J Heart Fail"},{"key":"605_CR17","doi-asserted-by":"publisher","first-page":"e010887","DOI":"10.1161\/JAHA.118.010887","volume":"8","author":"P Moliner","year":"2019","unstructured":"Moliner P, Enjuanes C, Tajes M, et al. Association between norepinephrine levels and abnormal iron status in patients with chronic heart failure: is iron deficiency more than a comorbidity? J Am Heart Assoc. 2019;8:e010887.","journal-title":"J Am Heart Assoc"},{"key":"605_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jacc.2011.01.059","volume":"58","author":"MT Maeder","year":"2011","unstructured":"Maeder MT, Khammy O, dos Remedios C, Kaye DM. Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. J Am Coll Cardiol. 2011;58:474\u201380.","journal-title":"J Am Coll Cardiol"},{"key":"605_CR19","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/ejhf.1154","volume":"20","author":"MF Hoes","year":"2018","unstructured":"Hoes MF, Grote Beverborg N, Kijlstra JD, Kuipers J, Swinkels DW, Giepmans BNG, et al. Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function. Eur J Heart Fail. 2018;20:910\u20139.","journal-title":"Eur J Heart Fail"},{"key":"605_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nrcardio.2011.77","volume":"8","author":"DJ van Veldhuisen","year":"2011","unstructured":"van Veldhuisen DJ, Anker SD, Ponikowski P, Macdougall IC. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat Rev Cardiol. 2011;8:485\u201393.","journal-title":"Nat Rev Cardiol"},{"key":"605_CR21","first-page":"362","volume":"38","author":"S Haddad","year":"2017","unstructured":"Haddad S, Wang Y, Galy B, Korf-Klingebiel M, Hirsch V, Baru AM, et al. Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure. Eur Heart J. 2017;38:362\u201372.","journal-title":"Eur Heart J"},{"key":"605_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ejhf.640","volume":"19","author":"V Melenovsky","year":"2017","unstructured":"Melenovsky V, Petrak J, Mracek T, Benes J, Borlaug BA, Nuskova H, et al. Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. Eur J Heart Fail. 2017;19:522\u201330.","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"605_CR23","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.3390\/ijms21093167","volume":"21","author":"P Severino","year":"2020","unstructured":"Severino P, D\u2019Amato A, Pucci M, Infusino F, Birtolo LI, Mariani MV, Lavalle C, Maestrini V, Mancone M, Fedele F. Ischemic heart disease and heart failure: role of coronary ion channels. Int J Mol Sci. 2020;21(9):3167.","journal-title":"Int J Mol Sci"},{"key":"605_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-1-4939-8597-5_16","volume":"1816","author":"SC Chang","year":"2018","unstructured":"Chang SC, Ren S, Rau CD, Wang JJ. Isoproterenol-induced heart failure mouse model using osmotic pump implantation. Methods Mol Biol. 2018;1816:207\u201320.","journal-title":"Methods Mol Biol"},{"issue":"10","key":"605_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13578-020-00434-y","volume":"24","author":"J Zhao","year":"2020","unstructured":"Zhao J, Lei Y, Yang Y, Gao H, Gai Z, Li X. Metoprolol alleviates arginine vasopressin-induced cardiomyocyte hypertrophy by upregulating the AKT1-SERCA2 cascade in H9C2 cells. Cell Biosci. 2020;24(10):72.","journal-title":"Cell Biosci"},{"key":"605_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s00392-016-1073-y","volume":"106","author":"S Von Haehling","year":"2017","unstructured":"Von Haehling S, Gremmler U, Krumm M, Mibach F, Schon N, Taggeselle J, et al. Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: the PrEP registry. Clin Res Cardiol. 2017;106:436\u201343.","journal-title":"Clin Res Cardiol"},{"key":"605_CR27","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/heartjnl-2014-305669","volume":"100","author":"A Cohen-Solal","year":"2014","unstructured":"Cohen-Solal A, Leclercq C, Deray G, Lasocki S, Zambrowski JJ, Mebazaa A, et al. Iron deficiency: an emerging therapeutic target in heart failure. Heart. 2014;100:1414\u201320.","journal-title":"Heart"},{"key":"605_CR28","doi-asserted-by":"publisher","first-page":"e004800","DOI":"10.1161\/CIRCHEARTFAILURE.117.004800","volume":"11","author":"V Melenovsky","year":"2018","unstructured":"Melenovsky V, Hlavata K, Sedivy P, et al. Skeletal muscle abnormalities and iron deficiency in chronic heart failurean exercise 31P magnetic resonance spectroscopy study of calf muscle. Circ Heart Fail. 2018;11:e004800.","journal-title":"Circ Heart Fail"},{"key":"605_CR29","doi-asserted-by":"publisher","first-page":"e014254","DOI":"10.1161\/JAHA.119.014254","volume":"9","author":"J N\u00fa\u00f1ez","year":"2020","unstructured":"N\u00fa\u00f1ez J, Mi\u00f1ana G, Cardells I, et al. Noninvasive imaging estimation of myocardial iron repletion following administration of intravenous iron: the myocardial-IRON trial. J Am Heart Assoc. 2020;9:e014254.","journal-title":"J Am Heart Assoc"},{"key":"605_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1540-8175.2011.01532.x","volume":"29","author":"R Gaber","year":"2012","unstructured":"Gaber R, Kotb NA, Ghazy M, Nagy HM, Salama M, Elhendy A. Tissue Doppler and strain rate imaging detect improvement of myocardial function in iron deficient patients with congestive heart failure after iron replacement therapy. Echocardiography. 2012;29:13\u20138.","journal-title":"Echocardiography"},{"key":"605_CR31","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/ejhf.938","volume":"20","author":"P Martens","year":"2018","unstructured":"Martens P, Verbrugge FH, Nijst P, Dupont M, Mullens W. Limited contractile reserve contributes to poor peak exercise capacity in iron-deficient heart failure. Eur J Heart Fail. 2018;20:806\u20138.","journal-title":"Eur J Heart Fail"},{"key":"605_CR32","doi-asserted-by":"crossref","unstructured":"Ren S, Chang S, Tran A, Mandelli A, Wang Y, Wang JJ. Implantation of an isoproterenol mini-pump to induce heart failure in mice. J Vis Exp 2019.","DOI":"10.3791\/59646"},{"key":"605_CR33","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/01.HYP.19.6.708","volume":"19","author":"M Nagano","year":"1992","unstructured":"Nagano M, Higaki J, Nakamura F, Higashimori K, Nagano N, Mikami H, et al. Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy. Hypertenxion. 1992;19:708\u201312.","journal-title":"Hypertenxion"},{"key":"605_CR34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/01.RES.73.1.184","volume":"73","author":"AM Feldman","year":"1993","unstructured":"Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 1993;73:184\u201392.","journal-title":"Circ Res"},{"key":"605_CR35","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.bbamcr.2012.05.010","volume":"1823","author":"CP Anderson","year":"2012","unstructured":"Anderson CP, Sher M, Eisenstein RS, Leibold EA. Mammalian iron metabolism and its control by iron regulatory proteins. Biochim BIophys Acta. 2012;1823:1468\u201383.","journal-title":"Biochim BIophys Acta"},{"key":"605_CR36","doi-asserted-by":"publisher","first-page":"12744","DOI":"10.1074\/jbc.R117.789537","volume":"292","author":"TA Rouault","year":"2017","unstructured":"Rouault TA, Maio N. Biogenesis and functions of mammalian iron-sulfur proteins in the regulation of iron homeostasis and pivotal metabolic pathways. J Biol Chem. 2017;292:12744\u201353.","journal-title":"J Biol Chem"},{"key":"605_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.celrep.2015.09.023","volume":"13","author":"W Xu","year":"2015","unstructured":"Xu W, Barrientos T, Mao L, Rockman HA, Sauve AA, Andrews NC. Lethal cardiomyopathy in mice lacking transferrin receptor in the heart. Cell Rep. 2015;13:533\u201345.","journal-title":"Cell Rep"},{"key":"605_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/jcp.10284","volume":"196","author":"Y Ke","year":"2003","unstructured":"Ke Y, Chen YY, Chang YZ, Duan XL, Ho KP, Jiang DH, et al. Post-transcriptional expression of DMT1 in the heart of rat. J Cell Physiol. 2003;196:124\u201330.","journal-title":"J Cell Physiol"},{"key":"605_CR39","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10741-018-9738-4","volume":"24","author":"KA Kobak","year":"2019","unstructured":"Kobak KA, Radwa\u0144ska M, Dzi\u0119ga\u0142a M, et al. Structural and functional abnormalities in iron-depleted heart. Heart Fail Rev. 2019;24:269\u201377.","journal-title":"Heart Fail Rev"},{"key":"605_CR40","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1210\/en.2006-1331","volume":"148","author":"U Merle","year":"2007","unstructured":"Merle U, Fein E, Gehrke SG, Stremmel W, Kulaksiz H. The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinology. 2007;148:2663\u20138.","journal-title":"Endocrinology"},{"key":"605_CR41","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1073\/pnas.1422373112","volume":"112","author":"S Lakhal-Littleton","year":"2015","unstructured":"Lakhal-Littleton S, Wolna M, Carr CA, Miller JJ, Christian HC, Ball V, et al. Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function. Proc Natl Acad Sci USA. 2015;112:3164\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"605_CR42","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.freeradbiomed.2018.08.010","volume":"133","author":"S Lakhal-Littleton","year":"2019","unstructured":"Lakhal-Littleton S. Mechanisms of cardiac iron homeostasis and their importance to heart function. Free Radic Biol Med. 2019;133:234\u20137.","journal-title":"Free Radic Biol Med"},{"issue":"99","key":"605_CR43","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1182\/blood.V99.10.3505","volume":"15","author":"FM Torti","year":"2002","unstructured":"Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood. 2002;15(99):3505\u201316.","journal-title":"Blood"},{"key":"605_CR44","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer S. The failing heart\u2014an engine out of fuel. N Engl J Med. 2007;356:1140\u201351.","journal-title":"N Engl J Med"},{"key":"605_CR45","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","volume":"14","author":"DA Brown","year":"2017","unstructured":"Brown DA, Perry JB, Allen ME, Sabbah HN, Stauffer BL, Shaikh SR, et al. Expert consensus document: mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol. 2017;14:238\u201350.","journal-title":"Nat Rev Cardiol"},{"key":"605_CR46","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1128\/MCB.01685-08","volume":"29","author":"PN Paradkar","year":"2009","unstructured":"Paradkar PN, Zumbrennen KB, Paw BH, Ward DM, Kaplan J. Regulation of mitocondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2. Mol Cell Biol. 2009;29:1007\u201316.","journal-title":"Mol Cell Biol"},{"key":"605_CR47","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00109-014-1147-0","volume":"92","author":"F Maccarinelli","year":"2014","unstructured":"Maccarinelli F, Gammella E, Asperti M, et al. Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity. J Mol Med (Berl). 2014;92:859\u201369.","journal-title":"J Mol Med (Berl)"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-021-00605-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-021-00605-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-021-00605-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T18:08:08Z","timestamp":1621274888000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-021-00605-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["605"],"URL":"https:\/\/doi.org\/10.1186\/s13578-021-00605-5","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"31 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol was approved by the local Institutional Ethics Committee of the Institut Municipal d\u2019Investigacions M\u00e8diques-Universitat Pompeu Fabra (CEEA-PRBB 16-1814I) and all animal procedures performed according to the guidelines from Directive 2010\/63\/EU of the European Parliament on the protection of animals used for scientific purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Josep Com\u00edn-Colet has received honoraria for speaking for Vifor Pharma and consultancy fees from Vifor Pharma.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}